Prostate Cancer - Results from #27660

Editor's Commentary - Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression June 20, 2011

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells - Abstract June 19, 2011

Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer - Abstract June 17, 2011

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies - Abstract June 17, 2011

Laparoendoscopic single site (LESS) radical prostatectomy: A review of the initial experience - Abstract June 17, 2011

Bipolar technology for transurethral prostatectomy - Abstract June 17, 2011

Developing imaging strategies for castration resistant prostate cancer - Abstract June 17, 2011

Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers - Abstract June 17, 2011

Dose escalation in prostate cancer using intensity modulated neutron radiotherapy - Abstract June 17, 2011

Penile rehabilitation after prostate cancer treatment: Outcomes and practical algorithm - Abstract June 17, 2011

Testosterone and prostate cancer: What are the risks for middle-aged men? - Abstract June 17, 2011

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer - Abstract June 17, 2011

Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. - Abstract June 16, 2011

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate - Abstract June 16, 2011

Evaluation of polygenic risk scores for predicting breast and prostate cancer risk - Abstract June 16, 2011

Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): An interim analysis of toxicity and efficacy - Abstract June 16, 2011

Tumor markers in prostate cancer I: Blood-based markers - Abstract June 16, 2011

State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer - Abstract June 16, 2011

Benzyldihydroxyoctenone, a novel nonsteroidal antiandrogen, shows differential apoptotic induction in prostate cancer cells in response to their androgen responsiveness - Abstract June 16, 2011

A miRNA expression signature that separates between normal and malignant prostate tissues - Abstract June 16, 2011

Page 1384 of 1435